Tectonic Advisors LLC Grows Stake in HealthEquity, Inc. $HQY

Tectonic Advisors LLC increased its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 122.6% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 76,931 shares of the company’s stock after purchasing an additional 42,378 shares during the quarter. Tectonic Advisors LLC owned 0.09% of HealthEquity worth $7,291,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of the company. True Wealth Design LLC increased its position in shares of HealthEquity by 3,522.2% in the third quarter. True Wealth Design LLC now owns 326 shares of the company’s stock valued at $31,000 after buying an additional 317 shares in the last quarter. Merit Financial Group LLC raised its holdings in shares of HealthEquity by 8.9% in the third quarter. Merit Financial Group LLC now owns 2,112 shares of the company’s stock worth $200,000 after acquiring an additional 172 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of HealthEquity in the third quarter valued at $341,000. Simplify Asset Management Inc. acquired a new stake in shares of HealthEquity during the third quarter valued at $1,498,000. Finally, First American Bank acquired a new stake in shares of HealthEquity during the third quarter valued at $1,633,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Stock Performance

Shares of HQY stock opened at $91.61 on Friday. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46. The company has a market cap of $7.83 billion, a PE ratio of 42.02, a P/E/G ratio of 1.32 and a beta of 0.20. The company’s fifty day simple moving average is $97.03 and its 200-day simple moving average is $95.52. HealthEquity, Inc. has a 52 week low of $74.07 and a 52 week high of $116.65.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.11. The firm had revenue of $322.16 million during the quarter, compared to the consensus estimate of $320.92 million. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The firm’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.78 EPS. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, equities research analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current year.

Analyst Upgrades and Downgrades

HQY has been the topic of a number of recent research reports. BTIG Research restated a “buy” rating and issued a $130.00 target price on shares of HealthEquity in a report on Thursday, December 4th. Barclays initiated coverage on shares of HealthEquity in a report on Monday, December 8th. They issued an “overweight” rating and a $118.00 target price for the company. BMO Capital Markets reaffirmed a “market perform” rating on shares of HealthEquity in a research note on Thursday, December 4th. Barrington Research reiterated an “outperform” rating and issued a $125.00 price target on shares of HealthEquity in a report on Thursday, December 4th. Finally, KeyCorp dropped their price objective on HealthEquity from $125.00 to $120.00 and set an “overweight” rating for the company in a report on Wednesday, October 8th. Two research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $120.27.

Insider Activity at HealthEquity

In related news, EVP Elimelech Rosner sold 10,959 shares of the business’s stock in a transaction that occurred on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the transaction, the executive vice president directly owned 45,742 shares of the company’s stock, valued at approximately $4,366,073.90. The trade was a 19.33% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Delano Ladd sold 1,500 shares of the stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $94.72, for a total transaction of $142,080.00. Following the completion of the sale, the executive vice president directly owned 73,979 shares of the company’s stock, valued at $7,007,290.88. This trade represents a 1.99% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 17,240 shares of company stock worth $1,640,164. 1.50% of the stock is currently owned by company insiders.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.